Effect of sizofiran on regional lymph nodes in patients with head and neck cancer

Biotherapy

Volumn 9, Issue 4, 1996, Pages 257-262

  Kano, Yuji ^a,b   Kakuta, Hiroyuki ^a   Hashimoto, Junichi ^a  

^a TEIKYO UNIVERSITY   (Japan)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Head and neck cancer; Immunofunction; Regional lymph node; Sizofuran (SPG)

Indexed keywords

BIOLOGICAL RESPONSE MODIFIER; INTERLEUKIN 2; SCHIZOPHYLLAN;

ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOTOXICITY; EFFECTOR CELL; HEAD AND NECK CANCER; HELPER CELL; HUMAN; IMMUNE FUNCTION TEST; IMMUNOMODULATION; INTRAMUSCULAR DRUG ADMINISTRATION; LYMPH NODE; LYMPH NODE METASTASIS; LYMPHOKINE ACTIVATED KILLER CELL; MONONUCLEAR CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030452559     PISSN: 0921299X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02620739     Document Type: Article

References (16)

1. Fume H. Biological characteristics and clinical effect of sizofilan(SPG). Drugs of Today 1987;23:335-46.
2. Mizuhira V, Ono M, Yokofujita J, Kinoshita M, Asano T, Hase T, Amemiya K. Histological and cytochemical studies on the distribution of schizophyllan glucan (SPG) in cancer-inoculated animaU.Differences in distribution and antitumor activity of 3H-SPG in sarcoma-180 inoculated females between ICR and DBA mice. Acta Histochem Cytochem 1985;18:221-54.
3. Sugawara I, Lee KC, Wong M. Schizophyllan (SPG)-treated macrophages and anti-tumor activities against syngeneic and allogeneic tumor cells. 1.Characteristics of SPG- treated macrophages. Cancer Immunol Immunother 1984; 16:137-44.
4. Okamura K, Suzuki M, Chihara T, Fujiwara A, Fukuda T, Goto S, Ichinohe K, Jimi S, Kasamatsu T, Kawai N, Mizuguchi K, Mori S, Nakano H, Noda K, Sekiba K, Suzuki K, Suzuki T, Takahashi K, Takeuchi K, Takeuchi S, Yajima A, Ogawa N. Clinical evaluation of schizophyllan combined with irradiation in patients with cervical cancer. A randomized controll study. Cancer 1986;58:865-72.
5. Shimizu Y, Hasumi K, Masubuchi K. Augmenting effect of Sizofiran on the immunofunction of regional lymph nodes in cervical cancer. Cancer 1992;69:1188-94.
6. Tsuchiya Y, Igarashi M, Inoue M, Kumagai K. Cytokinerelated immunomodulating activities of an anti-tumor glucan, sizofiran (SPG). J Pharmacobio-Dyn 1989;12: 616-25.
7. Tsucbiya Y, Yamamoto M, Igarashi M, Suzuki R, Kumagai K. Study on immunomodulating activity of an antitumor glucan, sizoflran at tumoral factor level. Clin Immunol 1986; 18:575-84.
8. Michel RA, Kessler DJ, Taylor JMG, Lichtenstein A. Natural killer cell cytotoxicity in the periferal blood, cervical lymph nodes, and tumor of head and neck cancer patients. Cancer Res. 1988;48:5017-22.
9. Snyderman CH, Heo DS, Johnson JT, D/Amico F, Barnes L, Whiteside TL. Functional and phenotypic analysis of lymphocytes in head and neck cancer. Arch Otolaryng 1991 ;117:899905.
10. Fisher B, Fisher ER. Studies concerning the regional lymph node in cancer:!. Initiation of immunity. Cancer 1971 ;27:10014.
11. Fisher B, Fisher ER. Studies concerning the regional lymph node in cancerll. Maintenance of immunity. Cancer 1972;29:1496-1501.
12. Fisher B, Saffer E, Fisher ER. Studies concerning the regional lymph node in cancer:FV. Tumor inhibition by regional lymph node cells. Cancer 1974;33:631-636.
13. BonillaF, Alvarez-Mon M, Merino F, Hera A, Ales JE, Espana P, Durantez A. Interleukin-2 induces cytotoxic activity in lymphocytes from regional axillary nodes of breast cancer patients. Cancer 1988;61:629-34.
14. Kimber I, Moore M, Howell A, Wilkinson MJS. Native and inducible levels of natural cytotoxicity in lymph nodes draining mammary carcinoma. Cancer Immunol Immunother 1983;15:32-38.
15. Eccles SA, Alexander P. Macrophage content of tumors in relation to metastatic spread and host immune reaction. Nature, Lon. 1974;250:667-69.
16. Hanna N, Burton R. Definitive evidence that natural killer (NK) cells inhibit experimental tumor metastasis in vivo. Immunology 1981:127:1754-58.